Calumet Specialty Products
CLMT
72 hedge funds and large institutions have $72.7M invested in Calumet Specialty Products in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 20 increasing their positions, 22 reducing their positions, and 10 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
0% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 10
9% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 22
1.11% less ownership
Funds ownership: 14.55% → 13.44% (-1.1%)
1% less funds holding
Funds holding: 73 → 72 (-1)
15% less capital invested
Capital invested by funds: $86M → $72.7M (-$13.3M)
66% less call options, than puts
Call options by funds: $4.78M | Put options by funds: $14M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DMK
David M. Knott
|
+$6.99M |
| 2 |
Goldman Sachs
New York
|
+$2.93M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.51M |
| 4 |
Barclays
London,
United Kingdom
|
+$739K |
| 5 |
BC
Barnett & Company
Chattanooga,
Tennessee
|
+$605K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$5.02M |
| 2 |
SPCM
Sound Point Capital Management
New York
|
-$4.44M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.63M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.93M |
| 5 |
Renaissance Technologies
New York
|
-$1.88M |
CLMT Hedge Fund Activity: Q1 2018 in Review
72 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Calumet Specialty Products (CLMT) for Q1 2018, worth a combined $72.7M — down 15% from $86M a quarter earlier.
Fund positioning in CLMT was balanced in Q1 2018: 10 funds opened new positions, 10 closed out, 20 added to existing stakes and 22 trimmed.
The largest buyer was David M. Knott, opening a new position worth an estimated $6.99M. The largest seller was Citigroup, cutting an estimated $5.02M.
- 72 institutional investors held Calumet Specialty Products (CLMT) as of Q1 2018, down from 73 in Q4 2017.
- Funds reported $72.7M of Calumet Specialty Products stock for Q1 2018, down 15% quarter-over-quarter.
- 10 funds opened new Calumet Specialty Products positions in Q1 2018 and 10 closed out, a net change of 0 holders.
- The largest Calumet Specialty Products buyer in Q1 2018 was David M. Knott, an estimated $6.99M added.
- The largest Calumet Specialty Products seller in Q1 2018 was Citigroup, an estimated $5.02M sold.
Based on aggregated 13F filings for Q1 2018.